Načítá se...
Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances
Oncolytic viruses are multifunctional anticancer agents with huge clinical potential, and have recently passed the randomized Phase III clinical trial hurdle. Both wild-type and engineered viruses have been selected for targeting of specific cancers, to elicit cytotoxicity, and also to generate anti...
Uloženo v:
| Vydáno v: | Oncolytic Virother |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4996257/ https://ncbi.nlm.nih.gov/pubmed/27579292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OV.S66083 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|